Has Sathish Shanmuga Sundara Perumal, MD received payments from drug or device companies?

Yes. Drug and device makers reported $1,180 in general payments to Sathish Shanmuga Sundara Perumal, MD across 56 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Sathish Shanmuga Sundara Perumal, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Sathish Shanmuga Sundara Perumal, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Sathish Shanmuga Sundara Perumal, MD

Family Medicine · Sharpsburg, GANPI 1659583938

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 56 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 22 manufacturers, the largest accounting for just 13.0% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $600, more than ten times the $15 reported in 2020.

$1,180in general payments, 2019–2025

Across 56 payments — averaging $21.06 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

AstraZeneca$153
Philips North America LLC$131
Lilly USA, LLC$129
Novo Nordisk$103
Dexcom, Inc.$97
Phathom Pharmaceuticals, Inc.$85
plus $482 from 16 others

What the payments were for

Food & beverage$1,180100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
AstraZeneca	9	$153
Philips North America LLC	1	$131
Lilly USA, LLC	7	$129
Novo Nordisk	4	$103
Dexcom, Inc.	5	$97
Phathom Pharmaceuticals, Inc.	5	$85
Sumitomo Pharma America, Inc.	3	$69
GSK	4	$67
Axsome Therapeutics, Inc.	2	$55
Bayer	2	$37
Boehringer Ingelheim	2	$37
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC	2	$33
Bausch Health US, LLC	1	$22
Otsuka America Pharmaceutical, Inc.	1	$21
Mylan Specialty L.p.	1	$21
Idorsia Pharmaceuticals US Inc	1	$20
AbbVie	1	$20
Johnson & Johnson	1	$19
Dynavax Technologies Corporation	1	$16
Amgen	1	$15
Pfizer	1	$15
Sanofi Pasteur Inc.	1	$15

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

(9124) LM Undivided$131

How this compares

$1,180 in reported general payments places this provider in the 60th percentile of 3,111 family medicine providers in Georgia.

See all family medicine providers in Georgia →

Medicare billing

Part B allowed, 2024

$42,114

Medicare patients

327

Services billed

531

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Azelastine Hcl	167	$3,173
Albuterol Sulfate HfaAlbuterol Sulfate	28	$810
Doxycycline Hyclate	69	$554
Diclofenac Sodium	18	$294
Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst	36	$257
Meclizine Hcl	53	$186
Triamcinolone Acetonide	24	$120
Montelukast Sodium	31	$120
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav	22	$99
Prednisone	33	$58
Pantoprazole Sodium	11	$48
Cephalexin	11	$44
Ciprofloxacin Hcl	16	$43
Meloxicam	31	$39
Tramadol Hcl	16	$23

Paid to pharmacies, not to this prescriber.

Other family medicine in Sharpsburg

Jeffrey KingsleyColumbus$404K
Debbie HaginsSavannah$279K
Yolanda WadeTyrone$233K
Julian HutchinsWarrenton$222K
Nadine Halliburton-FosterCumming$219K
Contessa MetcalfeAtlanta$157K
Elmore AlexanderStone Mountain$155K
Bantwal BaligaColumbus$115K
Avril CampbellFort Benning$108K
Mitzi RubinMarietta$103K

See the full list for Georgia →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →